140 related articles for article (PubMed ID: 2683580)
21. [Studies on piperaquine as long-acting antimalarial drug against Plasmodium berghei in mice].
Zhu DQ; Dai ZR; Li JC; Jiang ZK
Yao Xue Xue Bao; 1982 Dec; 17(12):894-8. PubMed ID: 6763837
[No Abstract] [Full Text] [Related]
22. Investigations of various extracts of Morinda lucida for antimalarial actions on Plasmodium berghei berghei in mice.
Obih PO; Makinde M; Laoye OJ
Afr J Med Med Sci; 1985; 14(1-2):45-9. PubMed ID: 2994438
[TBL] [Abstract][Full Text] [Related]
23. Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin.
Andrade AA; de Pilla Varotti F; de Freitas IO; de Souza MV; Vasconcelos TR; Boechat N; Krettli AU
Eur J Pharmacol; 2007 Mar; 558(1-3):194-8. PubMed ID: 17214980
[TBL] [Abstract][Full Text] [Related]
24. Chloroquine efficacy in Plasmodium berghei NK65-infected ICR mice, with reference to the influence of initial parasite load and starting day of drug administration on the outcome of treatment.
Ishih A; Suzuki T; Muregi FW; Matsui K; Terada M
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):13-7. PubMed ID: 16771206
[TBL] [Abstract][Full Text] [Related]
25. A novel chitosan based antimalarial drug delivery against Plasmodium berghei infection.
Tripathy S; Mahapatra SK; Chattopadhyay S; Das S; Dash SK; Majumder S; Pramanik P; Roy S
Acta Trop; 2013 Dec; 128(3):494-503. PubMed ID: 23906613
[TBL] [Abstract][Full Text] [Related]
26. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism.
He Z; Chen L; You J; Qin L; Chen X
Exp Parasitol; 2009 Oct; 123(2):122-7. PubMed ID: 19538959
[TBL] [Abstract][Full Text] [Related]
27. Screening of Morinda lucida leaf extract for antimalarial action on Plasmodium berghei berghei in mice.
Makinde JM; Obih PO
Afr J Med Med Sci; 1985; 14(1-2):59-63. PubMed ID: 2994441
[TBL] [Abstract][Full Text] [Related]
28. Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes.
Sánchez-Delgado RA; Navarro M; Pérez H; Urbina JA
J Med Chem; 1996 Mar; 39(5):1095-99. PubMed ID: 8676344
[TBL] [Abstract][Full Text] [Related]
29. [Effect of trifluoroacetoprimaquine on erythrocytic schizonts of rodent malaria].
Ye X; Shao B; Chu Y
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1994; 12(3):223-4. PubMed ID: 7867162
[TBL] [Abstract][Full Text] [Related]
30. The antimalarial activity of N-benzyl-oxydihydrotriazines. III. The activity of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(2,4,5,-trichloropropyloxy)-1,3,5-triazine hydrobromide (BRL 51084) and hydrochloride (BRL 6231).
Knight DJ; Mamalis P; Peters W
Ann Trop Med Parasitol; 1982 Feb; 76(1):1-7. PubMed ID: 7044322
[No Abstract] [Full Text] [Related]
31. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
[TBL] [Abstract][Full Text] [Related]
32. Antimalarial activity of the optical isomers of chloroquine diphosphate.
Haberkorn A; Kraft HP; Blaschke G
Tropenmed Parasitol; 1979 Sep; 30(3):308-12. PubMed ID: 396700
[TBL] [Abstract][Full Text] [Related]
33. [Synthesis and antimalarial and antineoplastic activities of some derivatives of 2,4-diamino-5-methyl-6-substituted benzylaminoquinazolines].
Meng XY; Zhang XP; Li BS; Li GD
Yao Xue Xue Bao; 1989; 24(8):578-86. PubMed ID: 2694758
[TBL] [Abstract][Full Text] [Related]
34. In Vivo antimalarial activity of aqueous extracts from Kenyan medicinal plants and their chloroquine (CQ) potentiation effects against a blood-induced CQ-resistant rodent parasite in mice.
Muregi FW; Ishih A; Suzuki T; Kino H; Amano T; Mkoji GM; Miyase T; Terada M
Phytother Res; 2007 Apr; 21(4):337-43. PubMed ID: 17221829
[TBL] [Abstract][Full Text] [Related]
35. Antimalarial activity of 1-aryl-3,3-dialkyltriazenes.
Nishiwaki K; Okamoto A; Matsuo K; Kawaguchi Y; Hayase Y; Ohba K
Bioorg Med Chem; 2007 Apr; 15(8):2856-9. PubMed ID: 17329108
[TBL] [Abstract][Full Text] [Related]
36. Plasmodium berghei: in vitro and in vivo activity of dequalinium.
Rodrigues JR; Gamboa de Domínguez N
Exp Parasitol; 2007 Jan; 115(1):19-24. PubMed ID: 16814285
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium berghei NK65: studies on the effect of treatment duration and inoculum size on recrudescence.
Nakazawa S
Exp Parasitol; 2005 Sep; 111(1):59-63. PubMed ID: 15961077
[TBL] [Abstract][Full Text] [Related]
38. [Omega-aminoacyl compounds against malaria].
Kölling H; Haberkorn A; Herbold B
Arzneimittelforschung; 1986 Feb; 36(2):230-3. PubMed ID: 3516160
[TBL] [Abstract][Full Text] [Related]
39. Effect of Azadirachta indica on Plasmodium berghei berghei in mice.
Obih PO; Makinde JM
Afr J Med Med Sci; 1985; 14(1-2):51-4. PubMed ID: 2994439
[TBL] [Abstract][Full Text] [Related]
40. Synergistic antimalarial activity of ketones with rufigallol and vitamin C.
Mahajan SS; Kamath VR; Ghatpande SS
Parasitology; 2005 Oct; 131(Pt 4):459-66. PubMed ID: 16174410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
